EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Active control of pharmacokinetics using light-responsive polymer-drug conjugates for boron neutron capture therapy

Daiki Tokura, Kakeru Konarita, Minoru Suzuki, Keisuke Ogata, Yuto Honda, Yutaka Miura, Nobuhiro Nishiyama, Takahiro Nomoto

Journal of Controlled Release · 2024

DOI: 10.1016/j.jconrel.2024.06.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2024. Verfasst von Daiki Tokura und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, 3-8-1 Komaba, Meguro-ku, Tokyo 153-8902, Japan; Laborator…. Hauptthemen laut MEDLINE: Boron Neutron Capture Therapy, Polymers. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Science and Technology Agency, Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In boron neutron capture therapy (BNCT), boron drugs should exhibit high intratumoral boron concentrations during neutron irradiation, while being cleared from the blood and normal organs. However, it is usually challenging to achieve such tumor accumulation and quick clearance simultaneously in a temporally controlled manner. Here, we developed a polymer-drug conjugate that can actively control the clearance of the drugs from the blood. This polymer-drug conjugate is based on a biocompatible polymer that passively accumulates in tumors. Its side chains were conjugated with the low-molecular-weight boron drugs, which are immediately excreted by the kidneys, via photolabile linkers. In a murine subcutaneous tumor model, the polymer-drug conjugate could accumulate in the tumor with the high boron concentration ratio of the tumor to the surrounding normal tissue (∼10) after intravenous injection while a considerable amount remained in the bloodstream as well. Photoirradiation to blood vessels through the skin surface cleaved the linker to release the boron drug in the blood, allowing for its rapid clearance from the bloodstream. Meanwhile, the boron concentration in the tumor which was not photoirradiated could be maintained high, permitting strong BNCT effects. In clinical BNCT, the dose of thermal neutrons to solid tumors is determined by the maximum radiation exposure to normal organs. Thus, our polymer-drug conjugate may enable us to increase the therapeutic radiation dose to tumors in such a practical situation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Boron Neutron Capture TherapyPolymersAnimalsCell Line, TumorBoron CompoundsLightFemaleMiceNeoplasmsBoronMice, Inbred BALB CHumans

Stichwörter der Autor:innen

Boron neutron capture therapyLight-responsive drug deliveryPolymer-drug conjugate

Substanzen

PolymersBoron CompoundsBoron

Autor:innen und Institutionen

  • Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, 3-8-1 Komaba, Meguro-ku, Tokyo 153-8902, Japan; Laboratory for Chemistry and Life Science, Institute of Innovative Research, To…
  • Division of Particle Radiation Oncology, Particle Radiation Oncology Research Center, Institute for Integrated Radiation and Nuclear Science, Kyoto University, 2-1010 Asashiro-nishi, Kumatori-cho, Sennan-gun, Osaka 590-…
  • Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 4259 Nagatsutacho, Midori-ku, Yokohama, Kanagawa 226-8503, Japan; Department of Life Science and Technology, Sc…

Förderung

  • Japan Science and Technology Agency
  • Ministry of Education, Culture, Sports, Science and Technology
  • Japan Society for the Promotion of Science
  • AMED

Zitieren

APA

Tokura, D., Konarita, K., Suzuki, M., Ogata, K., Honda, Y., Miura, Y., Nishiyama, N., & Nomoto, T. (2024). Active control of pharmacokinetics using light-responsive polymer-drug conjugates for boron neutron capture therapy. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2024.06.006

Vancouver

Tokura D, Konarita K, Suzuki M, Ogata K, Honda Y, Miura Y, et al. Active control of pharmacokinetics using light-responsive polymer-drug conjugates for boron neutron capture therapy. Journal of Controlled Release. 2024. doi:10.1016/j.jconrel.2024.06.006

BibTeX
@article{Tokura2024,
  author = {Tokura, Daiki and Konarita, Kakeru and Suzuki, Minoru and Ogata, Keisuke and Honda, Yuto and Miura, Yutaka and Nishiyama, Nobuhiro and Nomoto, Takahiro},
  title = {Active control of pharmacokinetics using light-responsive polymer-drug conjugates for boron neutron capture therapy},
  journal = {Journal of Controlled Release},
  year = {2024},
  doi = {10.1016/j.jconrel.2024.06.006}
}
Kostenlos starten →